Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
The Lancet. Oncology
|
May 31, 2025
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study
Caroline Robert, Michal Kicinski, Caroline Dutriaux, et al.
Autoimmunity Reviews
|
December 4, 2015
Kawasaki disease in adults: Observations in France and literature review
Jean-Baptiste Fraison, Pascal Sève, Claire Dauphin, et al.
The Lancet. Oncology
|
June 18, 2018
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
Brigitte Dreno, John F Thompson, Bernard Mark Smithers, et al.
Eclinicalmedicine
|
July 15, 2024
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
Alizée Bozonnat, Marie Beylot-Barry, Olivier Dereure, et al.
Eclinicalmedicine
|
December 25, 2024
Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
Alizée Bozonnat, Marie Beylot-Barry, Olivier Dereure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2025
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study
Adèle de Masson, Marie Beylot-Barry, Caroline Ram-Wolff, et al.
Lancet (London, England)
|
April 27, 2023
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
Adèle de Masson, Marie Beylot-Barry, Caroline Ram-Wolff, et al.
British Journal of Cancer
|
July 10, 2008
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
F Lesueur, M de Lichy, M Barrois, et al.
Cancers
|
July 24, 2021
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group
Candice Hober, Lisa Fredeau, Anne Pham-Ledard, et al.
Nature
|
October 21, 2011
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
The Lancet. Oncology
|
May 31, 2025
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAF<sup>V600E</sup> or BRAF<sup>V600K</sup> mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study
Caroline Robert, Michal Kicinski, Caroline Dutriaux, et al.
Autoimmunity Reviews
|
December 4, 2015
Kawasaki disease in adults: Observations in France and literature review
Jean-Baptiste Fraison, Pascal Sève, Claire Dauphin, et al.
The Lancet. Oncology
|
June 18, 2018
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
Brigitte Dreno, John F Thompson, Bernard Mark Smithers, et al.
Eclinicalmedicine
|
July 15, 2024
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
Alizée Bozonnat, Marie Beylot-Barry, Olivier Dereure, et al.
Eclinicalmedicine
|
December 25, 2024
Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study
Alizée Bozonnat, Marie Beylot-Barry, Olivier Dereure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2025
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study
Adèle de Masson, Marie Beylot-Barry, Caroline Ram-Wolff, et al.
Lancet (London, England)
|
April 27, 2023
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
Adèle de Masson, Marie Beylot-Barry, Caroline Ram-Wolff, et al.
British Journal of Cancer
|
July 10, 2008
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
F Lesueur, M de Lichy, M Barrois, et al.
Cancers
|
July 24, 2021
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group
Candice Hober, Lisa Fredeau, Anne Pham-Ledard, et al.
Nature
|
October 21, 2011
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, et al.
Page
of 8